364 related articles for article (PubMed ID: 8900274)
1. The PPARalpha-leukotriene B4 pathway to inflammation control.
Devchand PR; Keller H; Peters JM; Vazquez M; Gonzalez FJ; Wahli W
Nature; 1996 Nov; 384(6604):39-43. PubMed ID: 8900274
[TBL] [Abstract][Full Text] [Related]
2. Effect of peroxisome proliferator-activated receptor alpha activation on leukotriene B4 metabolism in isolated rat hepatocytes.
Fiedler J; Simon FR; Iwahashi M; Murphy RC
J Pharmacol Exp Ther; 2001 Nov; 299(2):691-7. PubMed ID: 11602682
[TBL] [Abstract][Full Text] [Related]
3. Inflammation. Signalling the fat controller.
Serhan CN
Nature; 1996 Nov; 384(6604):23-4. PubMed ID: 8900268
[No Abstract] [Full Text] [Related]
4. The peroxisome proliferator-activated receptor alpha (PPARalpha) ligand WY 14,643 does not interfere with leukotriene B4 induced adhesion of neutrophils to endothelial cells.
Heimbürger M; Palmblad J
Biochem Biophys Res Commun; 1998 Aug; 249(2):371-4. PubMed ID: 9712703
[TBL] [Abstract][Full Text] [Related]
5. Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation.
Nanji AA; Dannenberg AJ; Jokelainen K; Bass NM
J Pharmacol Exp Ther; 2004 Jul; 310(1):417-24. PubMed ID: 15016835
[TBL] [Abstract][Full Text] [Related]
6. [Effect of type of dietary fat and ethanol on hepatic leukotriene level in experimental alcoholic liver disease].
Satoh S; Uetake S; Ohata M; Nakajima H; Yamauchi M
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Aug; 38(4):350-63. PubMed ID: 14515744
[TBL] [Abstract][Full Text] [Related]
7. Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha.
Murakami K; Ide T; Suzuki M; Mochizuki T; Kadowaki T
Biochem Biophys Res Commun; 1999 Jul; 260(3):609-13. PubMed ID: 10403814
[TBL] [Abstract][Full Text] [Related]
8. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
Holness MJ; Bulmer K; Smith ND; Sugden MC
Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
[TBL] [Abstract][Full Text] [Related]
9. Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.
Cook WS; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
Biochem Biophys Res Commun; 2000 Nov; 278(1):250-7. PubMed ID: 11071880
[TBL] [Abstract][Full Text] [Related]
10. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
11. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.
Staels B; Koenig W; Habib A; Merval R; Lebret M; Torra IP; Delerive P; Fadel A; Chinetti G; Fruchart JC; Najib J; Maclouf J; Tedgui A
Nature; 1998 Jun; 393(6687):790-3. PubMed ID: 9655393
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-alpha regulates postischemic liver injury.
Okaya T; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G606-12. PubMed ID: 14615282
[TBL] [Abstract][Full Text] [Related]
13. PPARalpha-dependent induction of the energy homeostasis-regulating nuclear receptor NR1i3 (CAR) in rat hepatocytes: potential role in starvation adaptation.
Wieneke N; Hirsch-Ernst KI; Kuna M; Kersten S; Püschel GP
FEBS Lett; 2007 Dec; 581(29):5617-26. PubMed ID: 18023279
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) protein expression in oxidative skeletal muscle does not require the obligatory participation of peroxisome-proliferator-activated receptor alpha (PPARalpha).
Holness MJ; Bulmer K; Gibbons GF; Sugden MC
Biochem J; 2002 Sep; 366(Pt 3):839-46. PubMed ID: 12099888
[TBL] [Abstract][Full Text] [Related]
15. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver.
Romics L; Kodys K; Dolganiuc A; Graham L; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Aug; 40(2):376-85. PubMed ID: 15368442
[TBL] [Abstract][Full Text] [Related]
16. Lipid mediators of inflammation.
Robinson DR
Rheum Dis Clin North Am; 1987 Aug; 13(2):385-405. PubMed ID: 2827247
[TBL] [Abstract][Full Text] [Related]
17. [Metabolism and receptors of leukotriene B4].
Yokomizo T
Seikagaku; 2002 Sep; 74(9):1139-47. PubMed ID: 12402454
[No Abstract] [Full Text] [Related]
18. Chemical probes that differentially modulate peroxisome proliferator-activated receptor alpha and BLTR, nuclear and cell surface receptors for leukotriene B(4).
Devchand PR; Hihi AK; Perroud M; Schleuning WD; Spiegelman BM; Wahli W
J Biol Chem; 1999 Aug; 274(33):23341-8. PubMed ID: 10438511
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B4 in inflammation.
Ford-Hutchinson AW
Crit Rev Immunol; 1990; 10(1):1-12. PubMed ID: 2155000
[No Abstract] [Full Text] [Related]
20. [Current aspects of the inflammation phenomenon and mechanism of action of anti-inflammatory agents].
Dreux C
Sem Hop; 1983 Dec; 59(46):3173-6. PubMed ID: 6318333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
